ZORYVE foam 0.3% was safe, well-tolerated, and demonstrated durable and continuously improving efficacy in the treatment of seborrheic dermatitis up to 52 weeksOnce-daily ZORYVE foam 0.3% is approved ...

I’ve Always Used My Hair to Express My Emotions. Whether that’s wearing an afro or a braided mohawk or trying out a new color or haircut, my hair has always been my creative outlet. When I get my hair ...

The US Food and Drug Administration (FDA) has agreed to review a new drug application (NDA) for roflumilast foam 0.3% for treating seborrheic dermatitis in patients ages 9 years and older. If approved ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — Roflumilast foam 0.3% was efficacious in improving itch and quality of life in seborrheic dermatitis ...

Dandruff doesn't directly cause hair loss, but it can lead to it. Certain conditions that cause flakes and hair loss include ...

Human scalp with dandruff, computer illustration. Roflumilast is a highly potent and selective phosphodiesterase type 4 inhibitor. Positive topline results were announced from a phase 3 trial ...

The simplest guideline is that most men should be conditioning after every time they wash their hair. This will replenish the ...

It started out as a simple itch on the lower back of my head and ended with a scratch that kept me up at night. Thinking the annoying red patch that had formed in that area was dry skin, I started ...

New York — Seborrheic dermatitis (SD) is a common and shared disorder across populations, but it is the third most common dermatologic complaint that Black individuals bring to the dermatologist and ...